Long Term Trajectories of SMA Patients Receiving or Not Disease-modifying Treatments
Recruiting now
Conditions studied: Spinal Muscular Atrophy
In brief
This is an observational multicenter retrospective and prospective study on natural history of SMA also considering the 'new natural history' secondary to the availability of commercially available therapies. All the patients enrolled to date in the Italian registry, if not part of clinical trials, will be included in the present study.
Key facts
- Study ID
- NCT05768048
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- People needed
- 500
- Starts
- 2022-11-28
- Expected to finish
- 2027-11-27
- Last updated by the study team
- 2023-03-14
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- all patients with mutationsin the SMAN1 gene
You may not qualify if…
- unable to proviude consent
Where it is running
- Istituto Gaslini — Genova, Italy (enrolling)
- Nemo Sud — Messina, Italy (enrolling)
- Centro Clinico nemo — Milan, Italy (enrolling)
- Ospedale Bambino gesu — Rome, Italy (enrolling)
- Policlinico gemelli — Rome, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.